ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 174 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $731,391 | -73.1% | 35,695 | -73.9% | 0.00% | -100.0% |
| Q2 2023 | $2,719,031 | +546.5% | 136,841 | +457.4% | 0.00% | – |
| Q1 2023 | $420,576 | +30.6% | 24,552 | +49.2% | 0.00% | – |
| Q4 2022 | $321,985 | +77.9% | 16,453 | +45.0% | 0.00% | – |
| Q3 2022 | $181,000 | +1.1% | 11,346 | -12.7% | 0.00% | – |
| Q2 2022 | $179,000 | -25.1% | 12,996 | +19.0% | 0.00% | – |
| Q4 2021 | $239,000 | -78.5% | 10,925 | -70.6% | 0.00% | – |
| Q3 2021 | $1,111,000 | -42.0% | 37,165 | -14.1% | 0.00% | -100.0% |
| Q2 2021 | $1,917,000 | +61.1% | 43,288 | +61.4% | 0.00% | – |
| Q1 2021 | $1,190,000 | -36.1% | 26,817 | -21.0% | 0.00% | -100.0% |
| Q4 2020 | $1,861,000 | +309.9% | 33,935 | +70.9% | 0.00% | – |
| Q3 2020 | $454,000 | – | 19,853 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $11,354,000 | 10.44% |
| RTW INVESTMENTS, LP | 15,802,802 | $250,632,000 | 5.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 63,000 | $17,884,000 | 4.03% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,077,000 | 4.02% |
| Prosight Management, LP | 203,268 | $3,224,000 | 2.08% |
| COWEN AND COMPANY, LLC | 1,000,000 | $15,860,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,252,000 | 1.20% |
| Cormorant Asset Management, LP | 868,550 | $13,775,000 | 1.06% |
| Amitell Capital Pte Ltd | 97,331 | $1,544,000 | 0.90% |
| SECTORAL ASSET MANAGEMENT INC | 303,975 | $4,821,000 | 0.86% |